Initiation Archives - Page 260 of 272

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on Oyster Point Pharma (NASDAQ:OYST) with a Buy rating and announces Price Target of $20.

OYST

1 minute read

SVB Leerink Sees ‘Cheaper Way’ To Pharma Digital Marketing With This Stock

By Vandana Singh

July 15, 3:10 PM

SVB Leerink initiated coverage on OptimizeRx Corporation (NASDAQ:OPRX) with a buy rating and a price target of $38, implying an upside of…

DOCS

1 minute read

DA Davidson Initiates Coverage On Qualys with Neutral Rating, Announces Price Target of $120

By Benzinga Newsdesk

July 15, 8:41 AM

DA Davidson analyst Rudy Kessinger initiates coverage on Qualys (NASDAQ:QLYS) with a Neutral rating and announces Price Target of $120.

QLYS

1 minute read

SVB Leerink Initiates Coverage On Certara with Outperform Rating, Announces Price Target of $29

By Benzinga Newsdesk

July 15, 7:37 AM

SVB Leerink analyst Joy Zhang initiates coverage on Certara (NASDAQ:CERT) with a Outperform rating and announces Price Target of $29.

CERT

1 minute read

SVB Leerink Initiates Coverage On IQVIA Hldgs with Outperform Rating, Announces Price Target of $256

By Benzinga Newsdesk

July 15, 7:35 AM

SVB Leerink analyst Joy Zhang initiates coverage on IQVIA Hldgs (NYSE:IQV) with a Outperform rating and announces Price Target of $256.

IQV

1 minute read

SVB Leerink Initiates Coverage On Omnicell with Market Perform Rating, Announces Price Target of $124

By Benzinga Newsdesk

July 15, 7:28 AM

SVB Leerink analyst Joy Zhang initiates coverage on Omnicell (NASDAQ:OMCL) with a Market Perform rating and announces Price Target of $124.

OMCL

1 minute read

Wolfe Research Initiates Coverage On Sun Communities with Peer Perform Rating

By Benzinga Newsdesk

July 15, 6:06 AM

Wolfe Research analyst Andrew Rosivach initiates coverage on Sun Communities (NYSE:SUI) with a Peer Perform rating.

SUI

1 minute read

Goldman Sachs Initiates Coverage On Rover Group with Neutral Rating, Announces Price Target of $4.5

By Benzinga Newsdesk

July 15, 4:54 AM

Goldman Sachs analyst Eric Sheridan initiates coverage on Rover Group (NASDAQ:ROVR) with a Neutral rating and announces Price Target of $4.5.

ROVR